KDM5C
protein-codinglysine demethylase 5C, the group of Lysine demethylases|MicroRNA protein coding host genes|AT-rich interaction domain containing|PHD finger proteins
Gene summary
This gene is a member of the SMCY homolog family and encodes a protein with one ARID domain, one JmjC domain, one JmjN domain and two PHD-type zinc fingers. The DNA-binding motifs suggest this protein is involved in the regulation of transcription and chromatin remodeling. Mutations in this gene have been associated with X-linked cognitive disability. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2009]
- SMCX
- JARID1C
- MRX13
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~49.1 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: XL
Disease ID:MONDO:0010355
Submitter: Ambry Genetics
Inheritance Pattern: XL
Disease ID:MONDO:0100148
Submitter: ClinGen
*KDM5C* is located on chromosome Xp11.22 and encodes a lysine demethylase involved in transcriptional regulation. *KDM5C* was first reported in relation to X-linked complex neurodevelopmental disorder in 2005 (Jensen et al., PMID: 15586325). The clinical features of affected males include global developmental delay, intellectual disability (varying from mild to severe), speech impairment, seizures, short stature, mild dysmorphic features, and behavioral disorders including aggressive behavior, hyperactivity, and autism or autistic features. Other findings observed in some individuals include microcephaly, progressive spasticity, and visual problems. Female carriers are usually unaffected but can sometimes be mildly affected and present with short stature, dysmorphic features, or mild cognitive impairment. Eleven variants (nonsense, frameshift, splice, and missense) that have been reported in 11 probands in four publications (PMIDs: 15586325, 18697827, 21575681, 22326837) are included in this curation. Variants in this gene segregated with disease in additional family members. More evidence is available in the literature, but the maximum score for genetic evidence (12 points) has been reached. The mechanism of pathogenicity is loss of function. Patients with pathogenic variants display a specific peripheral blood epi-signature (PMID: 29456765). This gene-disease relationship is also supported by biochemical function, a mouse model (PMID: 26804915), and experiments in knockdown neurons (PMID: 17320160) and in patient-derived induced pluripotent stem cells (PMID: 38383780). Several other genes encoding lysine demethylases are involved in intellectual disability and autism. In summary, there is definitive evidence supporting the relationship between *KDM5C* and X-linked complex neurodevelopmental disorder. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This gene-disease pair was originally evaluated by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on September 19, 2018. It was reevaluated on August 12, 2026 (SOP Version 12). Although additional cases and experimental evidence were added, the classification did not change.
Inheritance Pattern: XL
Disease ID:MONDO:0010355
Submitter: G2P
Inheritance Pattern: XL
Disease ID:MONDO:0010355
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: XL
Disease ID:MONDO:0010355
Submitter: Orphanet
Inheritance Pattern: XL
Disease ID:MONDO:0010355
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Genitourinary; Musculoskeletal; Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to KDM5C variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_004187.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 36 | 204 | 19 | 259 | ||
| missense | 11 | 42 | 466 | 59 | 15 | 593 |
| nonsense | 38 | 17 | 21 | 76 | ||
| start loss | 1 | 1 | ||||
| frameshift | 48 | 31 | 1 | 80 | ||
| splice donor/acceptor (+/-2bp) | 4 | 20 | 33 | 57 | ||
| Total | 101 | 111 | 557 | 263 | 34 | 1066 |
Highest pathogenic variant AF is 0.000026458132
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_004178.2 | 26 | MANE Select | |
| Ensembl | ENSP00000364550.4 | 26 | MANE Select | |
| RefSeq | NP_001140174.1 | 24 | Standard | |
| RefSeq | NP_001269551.1 | 26 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| kdm5c | Danio rerio | Structure: whole organism Quality: curved ventral abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Pathways in clear cell renal cell carcinoma
- HDMs demethylate histones
- Chromatin modifying enzymes
- Chromatin organization
Biological Process
- negative regulation of transcription by RNA polymerase II
- chromatin remodeling
- histone H3-K4 demethylation
- histone H3-K4 demethylation, trimethyl-H3-K4-specific
- negative regulation of transcription, DNA-templated
Molecular Function
- DNA-binding transcription factor activity, RNA polymerase II-specific
- DNA binding
- protein binding
- zinc ion binding
- histone demethylase activity
Cellular Component
- nucleus
- nucleoplasm
- cytosol
- histone methyltransferase complex
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000375401
- Coding exons
- 26
- Length
- 34102
- Individuals with no LoFs
- 125742
- Homozygous LoFs
- 1
- Heterozygous LoFs
- 4
- Defined
- 125747
- p
- 0.0000199
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 5.15 | 293 | 667 | 0.439 | 0.0000572 | 10067 |
| Missense (PolyPhen) | 43 | 263.2 | 0.16337 | 4170 | ||
| Synonymous | -0.582 | 272 | 260 | 1.05 | 0.0000201 | 3210 |
| Loss of Function | 6.38 | 4 | 55.1 | 0.0726 | 0.00000433 | 846 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.000076 | 0.000062 | rare |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.000013 | 0.0000088 | rare |
| South Asian | 0.00016 | 0.000098 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Histone demethylase that specifically demethylates 'Lys- 4' of histone H3, thereby playing a central role in histone code (PubMed:28262558). Does not demethylate histone H3 'Lys-9', H3 'Lys-27', H3 'Lys-36', H3 'Lys-79' or H4 'Lys-20'. Demethylates trimethylated and dimethylated but not monomethylated H3 'Lys-4'. Participates in transcriptional repression of neuronal genes by recruiting histone deacetylases and REST at neuron-restrictive silencer elements. Represses the CLOCK-ARNTL/BMAL1 heterodimer- mediated transcriptional activation of the core clock component PER2 (By similarity). {ECO:0000250|UniProtKB:P41230, ECO:0000269|PubMed:17320160, ECO:0000269|PubMed:17320161, ECO:0000269|PubMed:17468742, ECO:0000269|PubMed:26645689, ECO:0000269|PubMed:28262558}.;
- Disease
- DISEASE: Mental retardation, X-linked, syndromic, Claes-Jensen type (MRXSCJ) [MIM:300534]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRXSCJ patients manifest mental retardation associated with variable features such as slowly progressive spastic paraplegia, seizures, facial dysmorphism. {ECO:0000269|PubMed:15586325, ECO:0000269|PubMed:16538222, ECO:0000269|PubMed:16541399, ECO:0000269|PubMed:17320160, ECO:0000269|PubMed:17468742, ECO:0000269|PubMed:23356856, ECO:0000269|PubMed:25666439}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.193
Intolerance Scores
- LoFtool
- 0.0636
- RVIS EVS
- -1.51
- RVIS percentile EVS
- 3.5
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- S
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.730
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |